We have developed a method for the isolation and culture of clonal populations of mouse skeletal muscle cells (SMSc). These cells can be genetically manipulated prior to injection into host (mouse) muscles where they will either take up 'satellite' cell positions, around the periphery of mature muscle fibres, or will differentiate and become incorporated into the muscle fibres of their host. Genetically modified SMSc will remain quiescent as satellite cells or as part of the host muscle for at least 15 months. Quiescent SMSc can also be reisolated from their host muscle and induced to proliferate in culture. We have shown that these SMSc are subject to growth factor survival and apoptotic signals and that they will undergo programmed cell death (apoptosis) when subject to IGF-I1 withdrawal. The mechanism of PCD in these skeletal muscle stem cells appears to be dependent o n caspase activity and involves the retinoblastoma protein pRb. Previously we showed that in dystrophic skeletal muscle cells P C D was elevated and that this cell death can be reduced by IGF-I1 . We have examined the expression pattern of pRb and caspase activity (PARP cleavage) in both normal and dystrophic mus- cIAP-I, cIAP-2, XIAP), regardless of the hydrogen peroxidetreated or untreated conditions, while no significant IAPs were detected in the parental or vector-transfected HL-60 cells. Mutagenesis of FAKcDNA revealed that Y397 and Y925, both of which are involved in the tyrosine-phosphorylation sites, were prerequisite for the anti-apoptotic activity as well as induction of IAPs, and K454 which is involved in the kinase-activity, was also required for the full anti-apoptotic activity of FAK. We investigated the effects of various apoptosis inducers on chromatin condensation and nuclear protein phosphorylation. The phosphorylation of all H I histone subtypes and of ubiquitinated H2A histones decreased rapidly after treatment with various apoptosis inducers. Whereas in TNFa-or anti-Fas-treated cells the phosphorylation of H3 histone subtypes decreased, this was not the case by treating the cells with phosphatase 1/2A inhibitors. Hyperphosphorylation of both the histone H2A.X and the ribosomal protein S6, however, was common to the treatment of all apoptosis inducing agents used. The addition of various kinase or phosphatase inhibitors during the induction of apoptosis resulted in a significant suppression of the apoptotic effects only in the case of the PARP inhibitor 3-aminobenzamide and still more pronounced by using the PKC activator PMA. The caspase inhibitors TP-CK and ZAPF-CK were also able to inhibit apoptosis and hyperphosphorylation of H2A.X. This study suggests that H2A.X phosphorylation might play a pivotal role in DNA condensation and fragmentation during processes of apoptosis. In order to assess the role of poly(ADP-rib0se)polymerase (PARP) in necrosis and apoptosis of cells, we examined the effect of PARPinhibitors on the two types of cell death of L1210 cells. Relatively high concentration of H202 (1 mM) caused a typical necrotic death of L1210 cells as characterized by the loss of membrane integrity and cell swelling without nucleosomal DNA fragmentation and caspase-activation. A potent PARP-inhibitor, DPQ (0.1 mM) almost completely suppressed the H202-induced necrosis. Another PARP-inhibitor, 3AB (3 mM) was also effective, although it was less effecient than DPQ. O n the other hand, calphostin C (500 nM), which is known to be a potent inhibitor of protein kinase C and to induce apoptosis in several cell lines through suppression of NF-kappaB activation, caused a typical apoptotic death of L1210 cells as characterized by activation of caspase-3 like enzyme and nucleosomal DNA fragmentation. In contrast to the effect on necrotic cell death, PARP-inhibitors, DPQ and 3AB did not suppress but markedly enhanced calphostin C-induced apoptotic cell death.
POLY(ADP-RIB0SE)POLYMERASE
PARP-deficient L1210 cell clone, which had been cloned in our laboratory and possessed approximately 6 % of PARP of wild type cells. In accord with the above observation with the use of PARP-inhibitors, PARP-deficiency almost completely abrogated H202-induced necrotic cell death, while the calphostin C-induced apoptosis was much higher in the mutant than in wild type L1210 cells.
death of L1210 cells, that is, necrotic cell death requires PARP, whereas PARP negatively regulates apoptosis of the cells.
We examined further the effect of H202 and calphostin C on a Taken together, these results indicate that PARP has dual roles in 0 2000 Biochemical Society
